Пошук


Поточні фільтри:


Почати новий пошук
Додати фільтри:

Використовуйте фільтри для уточнення результатів пошуку.


Результати 1-10 зі 17.
Знайдені матеріали:
Дата випускуНазваАвтор(и)
2020Clinical presentation, imaging and response to interferon‑alpha therapy in Erdheim–Chester disease: case‑based reviewIaremenko, O.; Petelytska, L.; Dyadyk, O.; Negria, N.; Fedkov, D.
2020Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritisIaremenko, O.; Shynkaruk, I.; Fedkov, D.; Iaremenko, K.; Petelytska, L.
2020Proteinase 3–antineutrophil cytoplasmic antibody (ANCA)–positive and ANCA–negative or myeloperoxidase–ANCA–positive patients with granulomatosis with polyangiitis: distinct patient subsetsPetelytska, L.; Iaremenko, O.
2020The efficacy and safety of inhaled acetylcysteine in comparison with oral acetylcysteine in chronic obstructive pulmonary disease: A randomized single-center studyKuzmenko, N.; Iaremenko, O.; Dobrianskiy, D.; Ilnytskyi, R.; Gumeniuk, G.
2021Cardiovascular risk in patients with osteoarthritis: results of the all-ukrainian study “PARTNER”Iaremenko, O.; Volodko, O.; Hrechanyk, N.; Vedenkina, L.; Ahafonova, N.; Brusentseva, S.; Doroshenko, G.; Komkina, M.
2021Clinical and immunological characteristics of patients with juvenile-, adult- and late onset systemic lupus erythematosusIaremenko, O.; Koliadenko, D.; Matiyashchuk, I.
2021Prevalence and clinical associations of neuropsychiatric symptoms among patients with systemic lupus erythematosusIaremenko, O.; Koliadenko, D.
2020The efficacy and safety of inhaled acetylcysteine in comparison with oral acetylcysteine in chronic obstructive pulmonary disease: A randomized single-center studyKuzmenko, N.; Iaremenko, O.; Dobrianskiy, D.; Ilnytskyi, R.; Gumeniuk, G.
2021Low back pain in men and women without spondyloarthritisIaremenko, O.; Mazanko, K.; Fedkov, D.; Dobrianskyi, D.; Smirnova, O.; Zhukova, V.
2022Sex‑related diferences in plasma amino acids of patients with ST‑elevation myocardial infarction and glycine as risk marker of acute heart failure with preserved ejection fractionIaremenko, O.; Iordanova, N.; Dudka, P.; Kuchmerovska, T.